Cell Therapeutics, Inc.

SEATTLE, Dec. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") rejected and dropped a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right could be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.

Dubai scheme..

WorldWatch reports that the economical situation of one of Europe’s oldest economies continues to fall, Portugal continues to have one of the worlds most expensive final consumer price for petrol in the entire world.

The cartel of price fixing is an open issue for anyone that wishes to confirm how the consumer prices are fixed, mostly on an upward scale.

The international crude price posted a fifth consecutive retreat, the lowest since 09-10-2009, crude oil for January delivery lost 1.7 percent to $72.68 a barrel in New York. , but this drop in prices has not been passed on to the consumer as should be the case,

The Portuguese population continues to pay the price as if the crude was quoted at $123 per barrel, this situation is approved by the government and so the petrol companies Galp, BP, Repsol and Cepsa continue to have record profits.

The demand forecast for petrol products is due to continue to fall as other economical issues emerge, after Dubai World’s Nakheel PJSC lost $3.65 billion, Fitch Ratings downgraded Greece’s credit and German industrial production unexpectedly dropped.

The economic recovery might not be as quick as people thought.